- STAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study findsBy doing hormone therapy upfront in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.STAT · 1mo ago↗ source
- Akeso, Summit drug extends survival in closely watched lung cancer trial<figure><div><img src="https://imgproxy.divecdn.com/U1p_j9BDqJ48JLk77g8bxOnzXIh5YVNKqCXZdq4xNwI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDcxMDQzNjg0LmpwZ…BioPharma Dive · 1mo ago↗ source
- ‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer<figure><div><img src="https://imgproxy.divecdn.com/WEayUdfuHXoOw2FpmsOFLF4yn7KYNOFOwzm5w7xXaT4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzE4Mjc5OTExLmpwZ…